Adalimumab in Adult Japanese Subjects With Psoriasis

Study Identifier
M04-702
CT.gov Identifier
NCT00647400
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact

844-663-3742 or [email protected]

Study Complete

Results Available

Scientific Result Summary
Available Language(s): English
Download document(s)

Study Details

Medical Condition
  • Dermatology - Psoriasis (PsO)
    • Study Drug
  • adalimumab
    • Phase
    Phase 2
    Sex
    Female & Male
    Age
    20+ years
    Inclusion and Exclusion Criteria
    Inclusion Criteria:
    - Participants who completed Study M04-688 (NCT00338754)
    Exclusion Criteria:
    - Participant is considered by the investigator, for any reason, to be an unsuitable candidate for the study

    Protocol Summary

    To evaluate efficacy, safety, and pharmacokinetics of adalimumab in Japanese participants

    with psoriasis

    Study Locations

    Location
    Status
    Location
    Site Ref # / Investigator 5491
    Bunkyo-ku, Japan
    Status
    Not applicable
    Location
    Site Ref # / Investigator 5429
    Chiyoda-ku, Japan
    Status
    Not applicable
    Location
    Site Ref # / Investigator 5464
    Fukuoka, Japan
    Status
    Not applicable
    Location
    Site Ref # / Investigator 5477
    Fukuoka, Japan
    Status
    Not applicable
    Location
    Site Ref # / Investigator 5492
    Fukuoka, Japan
    Status
    Not applicable
    Location
    Site Ref # / Investigator 5504
    Fukuoka, Japan
    Status
    Not applicable
    Showing {first} - {last} of {total} Results